Treatment of Alzheimer's disease with cholinesterase inhibitors
- PMID: 11375139
- DOI: 10.1016/s0749-0690(05)70072-0
Treatment of Alzheimer's disease with cholinesterase inhibitors
Abstract
The cholinergic system is the most severely affected neurotransmitter system in patients with Alzheimer's disease, and therapeutic strategies have been developed to restore cholinergic function in these patients. This article reviews the present status of cholinesterase inhibitors for the treatment of Alzheimer's disease. It then discusses treatment approaches and current and future issues regarding efficacy and safety.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical